RE:Any serious thoughts on the move the sp will makeTo Give a balanced view, how about a range of prices for all 3, using an "if" and "if not", rather than a "when"? Only seems fair. Problem is, might not be so much fun looking at the downside risk. I know the chances are very good for a positive outcome for all 3, but it is not a given. The possibility exists for 0/3, 1/3, 2/3, 3/3. So why not a price for each of those?
GoBBs wrote: when the FDA thumbs up the BLA? grants priority review? grants pediatric voucher? That's 3 targets. It's fun and we sure need some of that here!